Diabetic microvascular complications among adults with type 2 diabetes in Adama, central Ethiopia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 10 2024
Historique:
received: 16 07 2024
accepted: 21 10 2024
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 22 10 2024
Statut: epublish

Résumé

Microvascular complications, affecting small blood vessels, can lead to serious conditions such as kidney failure, painful nerve damage, and vision loss. Early detection and effective treatment of these issues are vital for improving patient outcomes and reducing healthcare expenses. Thus, this study aimed to assess diabetic microvascular complications among adults with type 2 diabetes in Adama, central Ethiopia. An institutional-based cross-sectional study was conducted among 381 adult type 2 diabetes patients. A computer-generated simple random sampling method was used to select study participants. Data were collected using a structured data extraction checklist. The collected data were entered into Epi info version 7.2 and exported to SPSS version 27 for processing and analysis. Binary logistic regression was employed to model the association between diabetic microvascular complications and explanatory variables. An adjusted odds ratio (AOR) with a 95% confidence interval (CI) was used to estimate the strength of association, and statistical significance was proclaimed at a p-value < 0.05. The prevalence of diabetic microvascular complications was 21.8% (95% CI: 17.8-25.6) with diabetic neuropathy being the most common (16.8%), followed by diabetic retinopathy (4.2%), and diabetic nephropathy (2.9%). Poor glycemic control (AOR = 2.00, 95% CI: 1.01-3.98), and a history of hypertension (AOR = 2.36, 95% CI: 1.39-4.00) were positively associated with the development of diabetic microvascular complications. Conversely, being aged 41-60 years (AOR = 0.35, 95% CI: 0.18-0.68) was negatively associated with the development of these complications. About one in five patients developed at least one diabetic microvascular complication. Age, poor glycemic control, and a history of hypertension were associated with the development of these complications. Therefore, intervening to improve glycemic control and manage hypertension is crucial in preventing the onset of diabetic microvascular complications.

Identifiants

pubmed: 39438643
doi: 10.1038/s41598-024-77183-2
pii: 10.1038/s41598-024-77183-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24910

Informations de copyright

© 2024. The Author(s).

Références

Lovic, D. et al. The growing epidemic of diabetes Mellitus. CVP. 18 (2), 104–109 (2020).
doi: 10.2174/1570161117666190405165911
Cheran, K. et al. The Growing Epidemic of Diabetes Among the Indigenous Population of Canada: A Systematic Review. Cureus [Internet]. 2023 Mar 15 [cited 2024 Jul 16]; https://www.cureus.com/articles/126446-the-growing-epidemic-of-diabetes-among-the-indigenous-population-of-canada-a-systematic-review
World Health Organization. Classification of diabetes mellitus. ; (2019).
Leslie, R. D., Palmer, J., Schloot, N. C. & Lernmark, A. Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. Diabetologia. 59 (1), 13–20 (2016).
pubmed: 26498592 doi: 10.1007/s00125-015-3789-z
Animaw, W. & Seyoum, Y. Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS One. 12 (11), e0187670 (2017).
pubmed: 29112962 pmcid: 5675402 doi: 10.1371/journal.pone.0187670
Gassasse, Z., Smith, D., Finer, S. & Gallo, V. Association between urbanisation and type 2 diabetes: an ecological study. BMJ Glob Health. 2 (4), e000473 (2017).
pubmed: 29104770 pmcid: 5663267 doi: 10.1136/bmjgh-2017-000473
Cho, N. H. et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 138, 271–281 (2018).
pubmed: 29496507 doi: 10.1016/j.diabres.2018.02.023
Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).
pubmed: 34879977 doi: 10.1016/j.diabres.2021.109119
Hossain, M. J., Al-Mamun, M. & Islam, M. R. Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci. Rep. 7 (3), e2004 (2024).
pubmed: 38524769 pmcid: 10958528 doi: 10.1002/hsr2.2004
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 40, S1–129 (2017).
Fowler, M. J. Microvascular and macrovascular complications of diabetes. Clin. Diabetes. 3, 116–122 (2011).
doi: 10.2337/diaclin.29.3.116
Merid, F., Getahun, F., Esubalew, H. & Gezahegn, T. Diabetic microvascular complications and associated factors in patients with type 2 diabetes in Southern Ethiopia. Front Endocrinol [Internet]. 2024 Jul 4 [cited 2024 Jul 9];15. https://www.frontiersin.org/journals/endocrinology/articles/ https://doi.org/10.3389/fendo.2024.1342680/full
Stolar, M. Glycemic Control and complications in type 2 diabetes Mellitus. Am. J. Med. 123 (3, Supplement), S3–11 (2010).
pubmed: 20206730 doi: 10.1016/j.amjmed.2009.12.004
Seid, M. A. et al. Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals, Ethiopia. Diabetol. Metab. Syndr. 13 (1), 86 (2021).
pubmed: 34404465 pmcid: 8369723 doi: 10.1186/s13098-021-00704-w
Bui, H. D. T. et al. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: a cross-sectional study. Ann. Trans. Med. 7, 325. https://doi.org/10.21037/atm (2019).
doi: 10.21037/atm
Bansal, D. et al. Microvascular complications and their associated risk factors in newly diagnosed type 2 diabetes mellitus patients. Int. J. Chronic Dis. 2014, 201423. https://doi.org/10.1155/2014/201423 (2014).
doi: 10.1155/2014/201423 pubmed: 26464850 pmcid: 4590918
Saiyed, N. S. et al. Risk factors of microvascular complications among type 2 diabetic patients using cox proportional hazards models: a cohort study in tabuk Saudi Arabia. J. Multidiscip Healthc. 15, 1619–1632. https://doi.org/10.2147/JMDH.S367241 (2022).
doi: 10.2147/JMDH.S367241 pubmed: 35923155 pmcid: 9342245
Dweib, M. & El Sharif, N. Diabetes-related microvascular complications in primary health care settings in the West Bank, Palestine. J. Clin. Med. 12, 6719. https://doi.org/10.3390/jcm12216719 (2023).
doi: 10.3390/jcm12216719 pubmed: 37959185 pmcid: 10649955
Cheema, S. et al. Risk factors for microvascular complications of diabetes in a high-risk middle east population. J. Diabetes Res. 2018, 7. https://doi.org/10.1155/2018/8964027 (2018).
doi: 10.1155/2018/8964027
Annani-akollor, M. E. et al. Predominant complications of type 2 diabetes in Kumasi: a 4-year retrospective cross-sectional study at a teaching hospi_tal in Ghana. Med. (B Aires). 55 (125), 1–11 (2019).
Jasper, U., Opara, M. & Pyiki, E. Prevalence and clinical pattern of acute and chronic complications in African diabetic patients. Br. J. Med. Med. Res. 4, 4908. https://doi.org/10.9734/BJMMR (2014).
doi: 10.9734/BJMMR
Korsa, A. T., Genemo, E. S., Bayisa, H. G. & Dedefo, M. G. Diabetes mellitus complica_tions and associated factors among adult diabetic patients in selected hospitals of west Ethiopia diabetes mellitus complications and associated factors among adult diabetic patients in selected hospitals of West Ethio_pia. Open. Cardiovasc. Med. J. 13, 41–48 (2019).
doi: 10.2174/1874192401913010041
Gebre, B. B. & Assefa, Z. M. Magnitude and associated factors of diabetic complication among diabetic patients attending gurage zone hospitals. South. West. BMC Res. Notes. 12 (780), 1–6. https://doi.org/10.1186/s13104-019-4808-9 (2019).
doi: 10.1186/s13104-019-4808-9
Sheleme, T., Mamo, G., Melaku, T. & Sahilu, T. Prevalence, patterns and predic_tors of chronic complications of diabetes mellitus at a large referral hospital in Ethiopia: a prospective observational study. Diabetes Metab. Syndr. Obes. Targets Ther. 13, 4909–4918 (2020).
doi: 10.2147/DMSO.S281992
Fasil, A. B. & Belete, A. M. Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia. Diabetes Metab. Syndr. Obes. Targets Ther. 12, 75–83 (2019).
doi: 10.2147/DMSO.S185614
An, T. Major microvascular complications and associated risk factors among endocrinology & metabolic syndrome major microvascular complications and associated risk factors among diabetic outpatients in Southwest Ethiopia. Endocrinol. Metab. Syndr. 6 (4), 1–10 (2017).
doi: 10.4172/2161-1017.1000272
Al-Shehri, F. S. Glycemic Control and Microvascular complications of type 2 diabetes among saudis. JDM. 09 (04), 167–175 (2019).
doi: 10.4236/jdm.2019.94016
Bansal, D. et al. Microvascular complications and their Associated Risk factors in newly diagnosed type 2 diabetes Mellitus patients. Int. J. Chronic Dis. 2014, 1–7 (2014).
doi: 10.1155/2014/201423
for the ADVANCE Collaborative group et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 57 (12), 2465–2474 (2014).
doi: 10.1007/s00125-014-3369-7
Hurst, C., Thinkhamrop, B. & Tran, H. T. The Association between Hypertension Comorbidity and Microvascular complications in type 2 diabetes patients: a nationwide cross-sectional study in Thailand. Diabetes Metab. J. 39 (5), 395 (2015).
pubmed: 26566497 pmcid: 4641969 doi: 10.4093/dmj.2015.39.5.395
Merid, F., Getahun, F., Esubalew, H. & Gezahegn, T. Diabetic microvascular complications and associated factors in patients with type 2 diabetes in Southern Ethiopia. Front. Endocrinol. 15, 1342680 (2024).
doi: 10.3389/fendo.2024.1342680
Thi Bui, H. D. et al. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: a cross-sectional study. Annals of Translational Medicine; Vol 7, No 14 (July 31, 2019): Annals of Translational Medicine [Internet]. [cited 2019 Jan 1]; (2019). https://atm.amegroups.org/article/view/26961
Ekoru, K. et al. Type 2 diabetes complications and comorbidity in Sub-saharan africans. EClinicalMedicine. 16, 30–41 (2019).
pubmed: 31832618 pmcid: 6890980 doi: 10.1016/j.eclinm.2019.09.001
Crasto, W., Patel, V., Davies, M. J. & Khunti, K. Prevention of Microvascular complications of Diabetes. Endocrinol. Metab. Clin. North Am. 50 (3), 431–455 (2021).
pubmed: 34399955 doi: 10.1016/j.ecl.2021.05.005
Marshall, S. M. & Flyvbjerg, A. Prevention and early detection of vascular complications of diabetes. BMJ. 333 (7566), 475–480 (2006).
pubmed: 16946335 pmcid: 1557968 doi: 10.1136/bmj.38922.650521.80
Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14 (2), 88–98 (2018).
pubmed: 29219149 doi: 10.1038/nrendo.2017.151
Federation, I. D. IDF Diabetes Atlas, tenth. Int. Diabetes ; (2021).
Taderegew, M. M. et al. Platelet Indices and Its Association with Microvascular complications among type 2 diabetes Mellitus patients in Northeast Ethiopia: a cross-sectional study. DMSO. 14, 865–874 (2021).
doi: 10.2147/DMSO.S300460
Kosiborod, M. et al. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc. Diabetol. 17 (1), 150 (2018).
pubmed: 30486889 pmcid: 6260731 doi: 10.1186/s12933-018-0787-8
Care, D. Standards of medical care in diabetes 2019. Diabetes Care. 42 (Suppl 1), S124–S138 (2019).
Gebremedhin, H. & Aregawi, B. G. Micro Vascular complications and Associated factors among type two Diabetic patients in Adigrat and Wkuro General hospitals, Northern Ethiopia: a retrospective cross-sectional study. J. Diabetes Metabolism. 11, 1–7 (2020).
Shita, N. G. & Isayu, A. S. Predictors of blood glucose change and microvascular complications of type 2 diabetes mellitus patients in Felege Hiwot and Debre Markos referral hospital, North West Ethiopia. BMC Endocr. Disord. 22 (1), 136 (2022).
pubmed: 35606785 pmcid: 9128238 doi: 10.1186/s12902-022-01047-x
An, T. et al. Major Micro vascular Complications and Associated Risk Factors among Diabetic Outpatients in Southwest Ethiopia. Endocrinol Metab Syndr [Internet]. 2017 [cited 2024 Jul 13];06(04). https://www.omicsonline.org/open-access/major-micro-vascular-complications-and-associated-risk-factors-amongdiabetic-outpatients-in-southwest-ethiopia-2161-1017-1000272.php?aid=92151
Berihun, L. & Muluneh, E. K. Correlates of time to microvascular complications among diabetes mellitus patients using parametric and non-parametric approaches: a case study of Ayder referral hospital, Ethiopia. Eth J. Sci. Technol. 10 (1), 65 (2017).
doi: 10.4314/ejst.v10i1.5
Hussein, M. & Menasri, S. Prevalence of Microvascular complications in type 2 diabetics attending a primary Healthcare Centre in Sudan. Dubai Diabetes Endocrinol. J. 25 (3–4), 127–133 (2019).
doi: 10.1159/000500914
Shillah, W. B., Yahaya, J. J., Morgan, E. D. & Bintabara, D. Predictors of microvascular complications in patients with type 2 diabetes mellitus at regional referral hospitals in the central zone, Tanzania: a cross-sectional study. Sci. Rep. 14 (1), 5035 (2024).
pubmed: 38424145 pmcid: 10904798 doi: 10.1038/s41598-024-55556-x
Ikem, R. T., Enikuomehin, A. C., Soyoye, D. O. & Kolawole, B. A. The burden of diabetic complications in subjects with type 2 diabetes attending the diabetes clinic of the Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria - a cross-sectional study. Pan Afr Med J [Internet]. [cited 2024 Jul 13];43. (2022). https://www.panafrican-med-journal.com/content/article/43/148/full
Alnaim, M. M., Alrasheed, A., Alkhateeb, A. A., Aljaafari, M. M. & Alismail, A. Prevalence of microvascular complications among patients with type 2 diabetes mellitus who visited diabetes clinics in Saudi Arabia. Saudi Med. J. 44 (2), 211 (2023).
pubmed: 36773970 pmcid: 9987703 doi: 10.15537/smj.2023.44.2.20220719
Cheema, S. et al. Risk factors for Microvascular Complications of Diabetes in a high-risk Middle East Population. J. Diabetes Res. 2018, 1–7 (2018).
doi: 10.1155/2018/8964027
Govindarajan Venguidesvarane, A. et al. Prevalence of vascular complications among type 2 Diabetic patients in a Rural Health Center in South India. J. Prim. Care Community Health. 11, 215013272095996 (2020).
doi: 10.1177/2150132720959962
Li, J. et al. Prevalence and associated factors of vascular complications among inpatients with type 2 diabetes: a retrospective database study at a tertiary care department, Ningbo, China. PLoS One. 15 (6), e0235161 (2020).
pubmed: 32574208 pmcid: 7310722 doi: 10.1371/journal.pone.0235161
Aikaeli, F. et al. Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis. Asweto CO, editor. PLOS Glob Public Health. ;2(6):e0000599. (2022).
Alaboud, A. F. et al. Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia. SMJ. 37 (12), 1408–1411 (2016).
doi: 10.15537/smj.2016.12.17062
Ungvari, Z., Kaley, G., De Cabo, R., Sonntag, W. E. & Csiszar, A. Mechanisms of vascular aging: New perspectives. Journals Gerontol. Ser. A: Biol. Sci. Med. Sci. 65A (10), 1028–1041 (2010).
doi: 10.1093/gerona/glq113
Seals, D. R., Jablonski, K. L. & Donato, A. J. Aging and vascular endothelial function in humans. Clin. Sci. 120 (9), 357–375 (2011).
doi: 10.1042/CS20100476
Strait, J. B. & Lakatta, E. G. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail. Clin. 8 (1), 143–164 (2012).
pubmed: 22108734 pmcid: 3223374 doi: 10.1016/j.hfc.2011.08.011
Ali, A. et al. Prevalence of microvascular complications in newly diagnosed patients with Type 2 diabetes. Pak J Med Sci [Internet]. Jun 10 [cited 2024 Jul 15];29(4). (2013). http://pjms.com.pk/index.php/pjms/article/view/3704
Kayar, Y. et al. Relationship between the poor glycemic control and risk factors, life style and complications. Biomed. Res. 28 (4), 1581–1586 (2017).
Oguntibeju, O. O. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int. J. Physiol. Pathophysiol Pharmacol. 11 (3), 45–63 (2019).
pubmed: 31333808 pmcid: 6628012
Nakamura, A. & Kawaharada, R. Advanced Glycation End Products and Oxidative Stress in a Hyperglycaemic Environment. In: Alok Raghav, Jamal Ahmad, editors. Fundamentals of Glycosylation [Internet]. Rijeka: IntechOpen; 2021 [cited 2024 Jul 16]. p. Ch. 2. https://doi.org/10.5772/intechopen.97234
Mauricio, D., Gratacòs, M. & Franch-Nadal, J. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovasc. Diabetol. 22 (1), 314 (2023).
pubmed: 37968679 pmcid: 10652502 doi: 10.1186/s12933-023-02056-3
Mengstie, M. A. et al. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. Front. Mol. Biosci. 9, 1002710 (2022).
pubmed: 36188225 pmcid: 9521189 doi: 10.3389/fmolb.2022.1002710
Tracey, M. L. et al. Risk factors for macro- and microvascular complications among older adults with diagnosed type 2 diabetes: findings from the Irish longitudinal study on Ageing. J. Diabetes Res. 2016, 1–9 (2016).
doi: 10.1155/2016/5975903
Del Cañizo Gómez FJ et al. Microvascular complications and risk factors in patients with type 2 diabetes. Endocrinología Y Nutrición. 58 (4), 163–168 (2011).
pubmed: 21411384 doi: 10.1016/j.endonu.2011.01.006
Dobrica, E. et al. Journal of Hypertension [Internet]. ;37. (2019). https://journals.lww.com/jhypertension/fulltext/2019/07001/macrovascular_and_microvascular_complications_in.391.aspx
Petrie, J. R., Guzik, T. J. & Touyz, R. M. Diabetes, hypertension, and Cardiovascular Disease: clinical insights and vascular mechanisms. Can. J. Cardiol. 34 (5), 575–584 (2018).
pubmed: 29459239 doi: 10.1016/j.cjca.2017.12.005
Lastra, G., Syed, S., Kurukulasuriya, L. R., Manrique, C. & Sowers, J. R. Type 2 diabetes Mellitus and Hypertension. Endocrinol. Metab. Clin. North Am. 43 (1), 103–122 (2014).
pubmed: 24582094 doi: 10.1016/j.ecl.2013.09.005

Auteurs

Yohannes Mekuria Negussie (YM)

Department of Medicine, Adama General Hospital and Medical College, Adama, Ethiopia. yohannes_mekuria@yahoo.com.

Midekso Sento (M)

Department of Biomedical sciences, Adama Hospital Medical College, Adama, Ethiopia.

Nesra Mohammed Fati (NM)

Department of Biomedical sciences, Adama Hospital Medical College, Adama, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH